Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn’s Disease

CAMEO

Condition: Gastroenterology
Clinicaltrials.gov ID: NCT05781152

What is the goal of the study?

With the CAMEO study we will focus on patients receiving optimized anti-TNF therapy within 180 days of diagnosis by utilization of frequent drug level monitoring and pharmacokinetic based dosage guidance, formalizing intestinal re-evaluation at standardized time-points with central adjudication, and fully characterizing the biologic profile of all participants.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Hengqi Zheng
Study Team Member: Danny Gagucas, Danny.Gagucas@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.